A Media Snippet accompanying this announcement is available by clicking on this link RIYADH, November 25th, 2023 – Elevatus, the premier recruitment solutions provider headquartered in Riyadh, announces its collaboration with Lebara Mobile KSA, the leading virtual mobile operator in Saudi Arabia. This collaboration represents a significant step forward for
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the “Class Period”), of the important December 26, 2023 lead plaintiff deadline.
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds investors of the common stock of Axsome Therapeutics, Inc. (“Axsome”) (NASDAQ: AXSM) of the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome and certain of
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both dates inclusive (the “Class Period”), of the important December 15, 2023 lead plaintiff deadline.